Tajuk : The chairman of the company behind the EpiPen made $98 million in 2016
link : The chairman of the company behind the EpiPen made $98 million in 2016
The chairman of the company behind the EpiPen made $98 million in 2016
Nir Elias/Reuters
Mylan chairman Robert J. Coury in 2015.
Mylan’s chairman Robert Coury made roughly $98 million in 2016, a year in which the company faced criticism for the price of the EpiPen and the stock fell almost 30%, according to company filings.
On top of that, The Wall Street Journal reported, Coury made $66.3 million in other payments, including retirement benefits, bringing the amount he made in 2016 to $164 million.
According to the filings, Coury will continue to receive $1.8 million a year. Coury had originally served as CEO of Mylan from 2002 to 2011. Before June 2016, Coury had served as executive chairman, a role he held since 2012 when Heather Bresch became CEO.
Mylan told the WSJ in a statement:
“During Mr. Coury’s long tenure, Mylan has delivered strong financial performance and shareholder growth, and his new compensation structure continues to be aligned with the company’s stock performance while providing shareholders with the benefit of his continued leadership and guidance in setting Mylan’s strategic direction.”
The generic pharmaceutical company came into the spotlight in August 2016 for raising the price of the EpiPen to $608.61 from $93.88 over the past decade. It caught the nation’s attention because parents were refilling their kids’ prescriptions, and some found that they were on the hook for hundreds of dollars for the device.
From May 2016 to May 2017, Mylan’s stock is down 12.4%.
NOW WATCH: The truth about corporate tax cuts
Read more stories on Business Insider, Malaysian edition of the world’s fastest-growing business and technology news website.
✍ Sumber Pautan : ☕ Business InsiderBusiness Insider
Kredit kepada pemilik laman asal dan untuk meneruskan bacaan di laman asal sila klik link atau copy paste ke web server : http://ift.tt/2pEvBM9
(✿◠‿◠)✌ Mukah Pages : Pautan Viral Media Sensasi Tanpa Henti. Memuat-naik beraneka jenis artikel menarik setiap detik tanpa henti dari pelbagai sumber. Selamat membaca dan jangan lupa untuk 👍 Like & 💕 Share di media sosial anda!
Nir Elias/Reuters
Mylan chairman Robert J. Coury in 2015.
Mylan’s chairman Robert Coury made roughly $98 million in 2016, a year in which the company faced criticism for the price of the EpiPen and the stock fell almost 30%, according to company filings.
On top of that, The Wall Street Journal reported, Coury made $66.3 million in other payments, including retirement benefits, bringing the amount he made in 2016 to $164 million.
According to the filings, Coury will continue to receive $1.8 million a year. Coury had originally served as CEO of Mylan from 2002 to 2011. Before June 2016, Coury had served as executive chairman, a role he held since 2012 when Heather Bresch became CEO.
Mylan told the WSJ in a statement:
“During Mr. Coury’s long tenure, Mylan has delivered strong financial performance and shareholder growth, and his new compensation structure continues to be aligned with the company’s stock performance while providing shareholders with the benefit of his continued leadership and guidance in setting Mylan’s strategic direction.”
The generic pharmaceutical company came into the spotlight in August 2016 for raising the price of the EpiPen to $608.61 from $93.88 over the past decade. It caught the nation’s attention because parents were refilling their kids’ prescriptions, and some found that they were on the hook for hundreds of dollars for the device.
From May 2016 to May 2017, Mylan’s stock is down 12.4%.
NOW WATCH: The truth about corporate tax cuts
Read more stories on Business Insider, Malaysian edition of the world’s fastest-growing business and technology news website.
✍ Sumber Pautan : ☕ Business InsiderBusiness Insider
Kredit kepada pemilik laman asal dan untuk meneruskan bacaan di laman asal sila klik link atau copy paste ke web server : http://ift.tt/2pEvBM9
(✿◠‿◠)✌ Mukah Pages : Pautan Viral Media Sensasi Tanpa Henti. Memuat-naik beraneka jenis artikel menarik setiap detik tanpa henti dari pelbagai sumber. Selamat membaca dan jangan lupa untuk 👍 Like & 💕 Share di media sosial anda!
dengan itu Perkara The chairman of the company behind the EpiPen made $98 million in 2016
Kini anda membaca artikel The chairman of the company behind the EpiPen made $98 million in 2016 dengan alamat pautan https://timesnewmalaysia.blogspot.com/2017/05/the-chairman-of-company-behind-epipen.html
Related Posts :
Kereta api ekspres rempuh rumah, tiga maut- “Itu cerita lama, saya sudah boleh terima hakikat” – Luah Nazeera Sardi bila tentang kisah cintanya bersama seorang pelawak popular yang baru-baru ini sudah berkahwin dengan rakan baiknya
- Padah berlagak sangat upload gambar berdiri atas kereta polis, kumpulan penjenayah curi motosikal dan basikal elektrik tumpas
- Kereta api ekspres rempuh rumah, tiga maut
- Padah berlagak sangat upload gambar berdiri atas kereta polis, kumpulan penjenayah curi motosikal dan basikal elektrik tumpas
0 Response to "The chairman of the company behind the EpiPen made $98 million in 2016"
Catat Ulasan